MARKET

VALN

VALN

Valneva Se
NASDAQ

Real-time Quotes | Nasdaq Last Sale

21.05
-1.65
-7.27%
Opening 14:45 07/01 EDT
OPEN
21.27
PREV CLOSE
22.70
HIGH
21.66
LOW
20.66
VOLUME
13.92K
TURNOVER
182.36K
52 WEEK HIGH
67.84
52 WEEK LOW
13.71
MARKET CAP
1.13B
P/E (TTM)
-12.3027
1D
5D
1M
3M
1Y
5Y
BRIEF-Pfizer Inc Reports 8.1% Passive Stake In Valneva SE As Of June 22
BRIEF-Pfizer Inc Reports 8.1% Passive Stake In Valneva SE As Of June 22
Reuters · 1d ago
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.
Benzinga · 4d ago
Valneva SE Declaration of shares and voting rights - Interim status at June 22, 2022
VALNEVA Declaration of shares and voting rights Interim status at June 22, 2022__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (Fra...
GlobeNewswire · 4d ago
BRIEF-Valneva Wins European Marketing Authorization For VLA2001 COVID-19 Vaccine
reuters.com · 06/24 16:26
Valneva announces European approval of COVID-19 vaccine
French biotech Valneva (NASDAQ:VALN) announced on Friday that the European Commission (EC) granted marketing authorization for its inactivated whole-virus COVID-19 vaccine, VLA2001, for primary vaccination in those aged 18 –
Seekingalpha · 06/24 16:22
Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session
Gainers USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.
Benzinga · 06/24 16:07
Anebulo, Tenon top healthcare gainers; BioSig, Rigel lead losers' pack
Gainers: Anebulo Pharmaceuticals (ANEB) +32%. Tenon Medical (TNON) +19%. PolarityTE (PTE) +14%. TRACON Pharmaceuticals (TCON) +14%. Bausch Health (BHC) +13%. Losers: BioSig Technologies (BSGM) -26%. Rigel Pharmaceuticals (RIGL) -8%. Valneva (VALN) -8%. Mer...
Seekingalpha · 06/24 14:05
Valneva's COVID-19 Vaccine Gets Marketing Authorization in Europe; Shares Down
MT Newswires · 06/24 12:45
More
No Data
Learn about the latest financial forecast of VALN. Analyze the recent business situations of Valneva Se through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

66.67%Strong Buy
33.33%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average VALN stock price target is 40.52 with a high estimate of 63.76 and a low estimate of 23.91.
High63.76
Average40.52
Low23.91
Current 20.94
EPS
Actual
Estimate
-1.16-0.87-0.58-0.29
Q4 2020
Q1 2021
Q2 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 11
Institutional Holdings: 137.68K
% Owned: 0.26%
Shares Outstanding: 53.86M
TypeInstitutionsShares
Increased
2
11.80K
New
4
27.71K
Decreased
2
16.91K
Sold Out
2
79
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.82%
Pharmaceuticals & Medical Research
+0.92%
Key Executives
Chairman - Supervisory/Director
Frederic Grimaud
Chairman - Management/President/Chief Executive Officer/Management Board
Thomas Lingelbach
President/Management Board
Franck Grimaud
Vice Chairman - Supervisory/Independent Director
James Sulat
Chief Financial Officer/Management Board
Peter Buhler
Chief Operating Officer
Perry Celentano
Senior Vice President/Executive Board
Andreas Meinke
Senior Vice President
Vincent Dequenne
Vice President - Finance/Executive Board
Manfred Tiefenbacher
Vice President/Director of Human Resources/Management Board
Gerald Strohmaier
Vice President/Director of Investor Relations
Joshua Drumm
Vice President/Executive Board
Jason Golan
Vice President/Executive Board
Olivier Jankowitsch
Vice President/Executive Board
Anna Ponten-engelhardt
Vice President/Executive Board
Klaus Schwamborn
General Counsel/Management Board/Secretary
Frederic Jacotot
Management Board
Janet Hoogstraate
Management Board
Juan Jaramillo
Management Board
Frances Muir
Independent Director/Supervisory Board
Anne-Marie Graffin
Independent Director/Supervisory Board
Johanna Pattenier
Independent Director/Supervisory Board
Sharon Tetlow
No Data
No Data
About VALN
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

Webull offers kinds of Valneva SE stock information, including NASDAQ:VALN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VALN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VALN stock methods without spending real money on the virtual paper trading platform.